Objectives. Bisphenol A (BPA) is a xenoestrogen, which is commonly used as a monomer of polycarbonate plastics food containers and epoxy resins. Little is known about the interaction effects between xeno-and phyto-estrogens on glucose homeostasis or other metabolic disorders. The aim of this study was to examine effects of individual or combined exposure to low doses of BPA and soy extract on glucose metabolism in mice with the goal to establish its potential mechanisms.
sible for the homeostasis, reproduction, growth, and behavior maintaining (Kavlock et al. 1996) . Therefore, an increasing number of studies have been conducted in response to great concerns raised about the possible role of these substances in the etiology of metabolic disorders. Bisphenol A (BPA) is an endocrine disruptor commonly used as a monomer in polycarbonate plastic food containers and epoxy resins coating metallic cans and the exposure to high temperatures and extreme pH can increase its leaching from cans and bottles into their contents (Brede et al. 2003) . Most people are continuously exposed to it through the environment and diet. Biomonitoring studies have reported detectable amounts of BPA at nanomolar levels in human serum (Vandenberg et al. 2007; Choi et al. 2017) .
Extensive literature has suggested that BPA is associated with chronic diseases such as diabetes, obesity, hypertension, cardiovascular disease (CVD), reproductive disorders, and cancer (Rezg et al. 2014; Seachrist et al. 2016) . Animal experiments have confirmed that BPA exposure may result in an abnormal glucose metabolism, loss of insulin secretion, and insulin resistance Song et al. 2014) . Alonso-Magdalena et al. (2006) were some of the first researchers who have shown that treatment of male mice with 100 µg/kg/day of BPA or 17β-estradiol (E2) induced insulin resistance and postprandial hyperinsulinemia. Previously, the majority of studies have considered BPA to be a weak xenoestrogen or environmental estrogen by focusing on nuclear mechanisms of estrogen receptors (ERs) (Fang et al. 2000) . The subsequent studies have shown that BPA at low concentrations may induce rapid extra-nuclear responses via ERs located on the plasma membrane and other hormone pathways. These more recent mechanisms have been found in environmentally relevant doses of BPA that are below the pharmacological concentration range (Yoon et al. 2014; Acconcia et al. 2015) .
In the real world, we are exposed to mixtures of EDCs, which most are anthropogenic but some, including soy isoflavones, are natural. Isoflavones are the main phytoestrogens in human food and soybean as a rich source has the highest known concentration of isoflavones, including genistein and daidzein (Albini et al. 2014) . Soy foods are reported to have numerous health benefits on different biological functions and thus many experts have recommended soy product consumption. Food and Drug Administration (FDA) was the first to formally recognized the benefit of soy protein and suggested daily consumption of 25 g of soy protein (Anderson and Bush 2011; Messina 2016) . Although soy isoflavones are known to be phytoestrogens, they can also exert endocrine disrupting actions through their estrogen agonist/ antagonist properties (Wuttke et al. 2008; Albini et al. 2014) .
Soy consumption is growing in popularity and BPA exposure has become continuous and ubiquitous. Therefore it is important to understand how dietary and environmental exposures may interact. Soy isoflavone has been shown to counteract epigenetic changes conferred by early life BPA exposure in the agouti mouse (Dolinoy et al. 2007) . Another study has shown that male rats exposed to BPA plus a soy diet, but not BPA alone, had lighter testes (Cao et al. 2015) .
Little is known about the interaction effects between xeno-and phyto-estrogens on glucose homeostasis. To the best of our knowledge, no previous study has examined the effects of combined exposure to low doses of BPA and soy extract on glucose biomarkers, oxidative stress status, and reproductive hormone testosterone levels at the same time, especially in male mice. Here, we extensively evaluated the effects of BPA and soy extract on these metabolic parameters, alone and in combination.
Materials and methods

Extraction of soybeans. Soybeans (Glycine Max)
were supplied by Behpak Industrial Company (Behshahr, Iran). It was scientifically identified by a botanist and a voucher specimen (jps017115) was deposited at the Herbarium of the Pharmacognosy Department, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences (AJUMS). The soybean seeds were ground into small pieces. One kilogram of crumbled seeds was macerated in methanol 80% (v/v) (Merck, Germany) at room temperature for 72 h with intermittent shaking at 2-hour intervals. The extract was filtered through Whatman papers (No. 1) then concentrated by a rotary vacuum evaporator at 40 °C in order to reduce the volume of the extract. Since the presence of methanol in the extract can influence the animal response, the extract was freeze-dried (OPR-FDCF-12012, Operon, Korea) for 48 h (Giribabu et al. 2014) . All processes were performed by the Medicinal Plant Research Center of AJUMS. The soy extract was stored at 10 °C until time of use. The yield of the plant extraction was 3.74% (w/w).
Animal treatment. Adult male NMRI mice aged 2-2.5 months (25-30 g) were obtained from the animal house of AJUMS (Ahvaz, Iran). All experiments and protocols were conducted in accordance with the general guidelines for the use and care of animals used for scientific purposes and approved by the Eth-ics Committee of AJUMS (reference No. IR.AJUMS. REC.1394.524). Mice were maintained under standard conditions (22±2 °C, 35%-60% humidity, 12 h light/12 h dark cycle) with free access to food and water throughout the experimental period. Both water bottles and cages were devoid of BPA. After a 1-week adaptation period, animals were randomly divided into six groups containing nine mice in each as follows: I) negative control group, administered distilled water; II) BPA group, received 100 µg/kg of BPA (2,2-Bis 4-hydroxyphenyl propane) (MERCK, Germany); III) soy 1 group, received 60 mg/kg soy extract; IV) soy 2 group, received 150 mg/kg soy extract; V) BPA + soy 1 group, received BPA (100 µg/kg) and soy extract (60 mg/kg); VI) BPA + soy 2 group, received BPA (100 µg/kg) and soy extract (150 mg/kg).
Distilled water containing 0.1% ethanol was used as the vehicle (Song et al. 2014 ) for the BPA solution, which was administered subcutaneously for 4 weeks. The soy-treated groups received soy extract by daily gavage feeding for the same time period. BPA (Ahangarpour et al. 2016 ) and soy extract dosages (Liu et al. 2008; Yu et al. 2010) were chosen based on previous studies.
Blood collection. Twenty-four hours after the last treatment following an overnight fasting period, the mice were anesthetized. Immediately, blood samples were collected through cardiac puncture and centrifuged at 3000 rpm for 20 min, then the serum was separated out and kept at -80 °C for subsequent analysis of serum parameters.
Biochemical assays. Fasting blood glucose (FBS) was measured in each sample obtained from the tail vein using an Accu-check compact glucometer (Performa, Germany). Serum insulin concentration was measured by a mouse insulin enzyme-linked immunosorbent assay (ELISA) kit (Mercodia, No. 10-1247-01, Sweden) . The homeostatic model assessment-β cell function (HOMA-β index) was calculated according to the following formulas (Matthews et al. 1985) :
Serum adiponectin level was determined by a mouse ELISA kit (Eastbiopharm, No. CK-E20456, USA) according to the manufacturer's instructions. The serum level of testosterone was assessed using a commercial ELISA mouse kit (BioVendor, No. RTC001R, Czech Republic). A colorimetric assay kit (ZellBio GmbH, No. ZB-TAC-96A, Germany) was used for measurement of serum total antioxidant capacity (TAC), and a colorimetric assay kit (ZellBio GmbH, No. ZB-MDA-96A, Germany) was used to measure the serum level of malondialdehyde (MDA). The TAC concentration was considered as the amount of antioxidant in the sample that compared with ascorbic acid action as the standard.
Statistical Analysis. Data were assessed for normality by the Shapiro-Wilk test, which confirmed normal distribution of data. Statistical evaluation was performed with one-way analysis of variance (ANOVA) followed by a Tukey post-hoc test using SPSS software (version 17.0). The results are presented as mean ± SEM (standard error of mean) and p<0.05 was defined as statistically significant.
Results
Effect of soy extract and BPA on FBS, insulin level, and HOMA-β. Administration of BPA caused a reduction in insulin concentration and HOMA-β and an increase in FBS level compared with the control group as shown in Table 1 (p<0.01, p<0.001, and p<0.001; respectively).
Treatment with both 60 and 150 mg/kg doses of soy extract significantly reduced FBS levels in the BPA + Table 1 Effect of bisphenol A (BPA) and soy extract alone or in combination on fasting blood glucose, insulin, adiponectin levels, and homeostatic model assessment-β cell function (HOMA-β). soy 1 and BPA + soy 2 groups compared with the BPA group (p<0.001 and p<0.001, respectively). However, FBS levels were still significantly higher in the BPA + soy 1 (p<0.001) and BPA + soy 2 (p<0.05) groups than that of the control group. Insulin levels increased after soy treatment in the BPA + soy groups but only the increase in the BPA + soy 2 group was statistically significant (p<0.05) compared with the BPA group. Also, showing a similar effect, 150 mg/kg soy extract increased the HOMA-β value in BPA + soy 2 group as compared with the BPA group (p<0.01). Effect of soy extract and BPA on serum levels of adiponectin. Daily injection of BPA alone remarkably reduced the adiponectin level when compared with the control group (p<0.01). No increase in adiponectin level was detected in response to soy extract treatment (Table 1) .
Effect of soy extract and BPA on serum levels of TAC and MDA. The TAC level declined (p<0.05) and the MDA level increased (p<0.001) significantly in the BPA group in comparison with control group. TAC levels were significantly higher in the soy 1 (p<0.05) and soy 2 (p<0.01) groups than in the BPA group. However, only 150 mg/kg dose extract administration showed a significant increase in TAC (p<0.05) and a decrease in MDA levels (p<0.01) in the BPA + soy 2 group compared with BPA group (Figure 1A,B) .
Effect of soy extract and BPA on serum levels of testosterone. As shown in Figure 1C , a significant reduction in testosterone concentration was observed in the BPA group in comparison with control group (p<0.01). Moreover, levels of this hormone were significantly lower in the BPA + soy 1 (p<0.01) and BPA+soy2 (p<0.01) groups than that of control group.
Discussion
BPA can be easily accumulated in the lipid rich tissues and act as a xenoestrogen or environmental estrogen, which means that it is chemically able to bind to estrogen receptors and exert estrogenic effects (Acconcia et al. 2015) . It is noteworthy that previ- ous studies have focused more on interaction effects between BPA and soy on reproductive hormones. However these compounds could also have potential influences on gluco-regulatory hormones due to endocrine disruptive properties. Therefore, in the current study, we evaluated the effect of co-exposure to estrogen active chemicals (EAC) on glucose homeostasis in an animal model. The possible biochemical mechanisms were studied by measuring the serum levels of testosterone, TAC, and MDA.
In this study, BPA exposure resulted in an abnormal glucose homeostasis through decreased insulin and elevated glucose levels. The same finding has been also shown by Ahangarpour et al. (2016) , who have reported pancreatic cell apoptosis, hyperglycemia, and a reduction in insulin secretion induced by 100 µg/kg of BPA, which is the same dose that we used.
On the other hand, some experimental studies data, slightly different from our one, have found hyperinsulinemia and insulin resistance in BPA-treated mice (Alonso-Magdalena et al. 2006; Angle et al. 2013; Song et al. 2014) . This rather contradictory result may be due to differences between strains of mice, because there is a strong evidence that the effects of BPA vary with duration, doses, route of exposure, species, and sex .
BPA exposure strongly decreased HOMA-β in comparison with the intact mice in the control, soy 1 and soy 2 groups in this study. HOMA-β is a valid and widely used index to evaluate the function of islet β-cells in pancreas and insulin secretion. The lower are HOMA-β score, the more serious β-cell injuries represent. Our results for HOMA-β also confirmed inability of pancreatic insulin secretion following BPA administration.
Our findings demonstrate that soy extracts could attenuate glucose metabolism dysfunction in mice co-exposed to BPA and soy extract via modulating reduction of FBS and increments of insulin concentration and HOMA-β with a greater effect at higher dose of soy extract. Several studies have confirmed that BPA exposure is associated with mitochondrial defects leading impairment and failure of pancreatic β-cells. Indeed, BPA induces dysfunction of insulin secretion and apoptosis through the damage of mitochondria. They have also reported disruption of mRNA expression of genes playing a key role in β-cell function (Glut2, Gck, Pdx1 and Snap25), and mitochondrial function (Ucp2 and Ogdh) (Song et al. 2012; Lin et al. 2013) .
Accumulating evidence supports the health benefits of soy, which can be widely attributed to the presence of isoflavones in the soybean. Soy isoflavones have direct effect on β-cells proliferation, providing protection against apoptosis and glucose-stimulated insulin secretion (Gilbert and Liu 2013) . Interestingly, some evidence suggested that the insulinotropic effect and β-cell proliferation related to soy isoflavones are neither dependent on its known activities as an antioxidant nor estrogen receptor agonist but are mediated via activation of the cAMP-dependent protein kinase (cAMP/PKA) cascade. Genistein could increase intracellular cAMP, PKA activity, and active extracellular signal-regulated protein kinases 1 and 2 (ERK1/2). These actions lead to enhancement in the protein expression of cyclin D1, a major cellcycle regulator in β-cell growth. Elevation of cAMP also activates some factors, which contribute to insulin exocytosis (Fu et al. 2010) .
Soy isoflavones also reduce hyperglycemia with the probable mechanisms of activating glucose transporter-4 (Glut4) translocation to plasma membrane and mitochondrial biogenesis modulated by the AMP-activated protein kinase (AMPK) pathway (Cederroth et al. 2008; Cheong et al. 2014) .
BPA has shown that reduced expression of Pdx1 and Glut2 mRNA while Procyanidin A2 known as a member of polyphenolic family increased mRNA levels of these genes. So, the mechanisms, by which isoflavones may exert their physiological effects on glucose transports appear to be common with those of the other polyphenols (Yang et al. 2015; Ahangarpour et al. 2016) . These findings suggest possible mechanisms that soy extract (150 mg/kg) could possibly normalize the level of glycemia along with providing an ability to protect β-cells function in mice simultaneously exposed to BPA and soy in the current study.
Although the FBS was within the normal range in animals treated by soy extracts alone, a slight but not significant increase in FBS was observed. Interestingly, higher baseline glucose levels in animals reared on a soy diet, not BPA was observed by Patisaul et al. (2014) . It has been proposed that either excessive or abnormal concentrations of chemicals with estrogenic activity can enhance the risk of diabetes (AlonsoMagdalena et al. 2006) . On this basis, interpretation of the results may be complicated and it may be difficult to accurately predict the responses based only on the estrogenic effect. Therefore, extensive studies should be performed to verify the dose-response mechanisms for this effect.
Adiponectin levels in all BPA exposure groups including BPA, BPA + soy 1 and BPA + soy 2 were significantly lower than in the control and showed the soy extract could not alter relatively strong effect of BPA on this hormone observed in the current study. Adiponectin is an adipokine involved in a number of metabolic processes, including glucose regulation, activation of insulin signal pathways such as AMPK, and fatty acid oxidation . In agreement with the earlier studies (Angle et al. 2013; Song et al. 2014) , the decreased levels of adiponectin induced by BPA in our study, is a critical factor in mediating hyperglycemia. The underlying mechanisms for BPA action in inhibiting adiponectin secretion are not clearly established, but it could be due to the effects of BPA on adipocyte differentiation and interference with glucose homeostasis in adipocytes (Sakurai et al. 2004; Ariemma et al. 2016) . A more recent research has pointed out that BPA could interact with nuclear receptors known as peroxisome proliferator-activated receptors (PPARs). PPARs contribute in the pathology of diabetes through dysregulation of adipocytokines such as adiponectin (Song et al. 2014; Li et al. 2015) . Therefore, it is hypothesized that BPA probably due to this mechanism, may affect the adiponectin secretion. Such activity requires to be confirmed both in vivo and in vitro conditions. Both BPA and soy phytoestrogen are able to interact with PPARs, but they are considered to have different consequences, surprisingly. Since soy has been reported to act as PPAR activator that can lead to up-regulation of adiponectin gene expression and increase adiponectin secretion (Oliva et al. 2015; Sakamoto et al. 2016) . However, we found that soy extract of 60 mg/kg and 150 mg/kg did not alter serum adiponectin levels. This may possibly be due to the relatively short period of time of soy extract treatment. Further studies with a longer duration are required to determine whether similar results are found.
In recent years, a large number of experimental studies have been undertaken to establish the possible mechanisms of BPA. They have suggested that independent of an estrogenic effect, BPA can disrupt the oxidant-antioxidant balance. Nrf2 transcription pathway is a known underlying mechanism of the BPA-mediated effect upon antioxidant enzyme activity. Both BPA and soy isoflavones trigger this pathway. Soy isoflavone can attenuate oxidative stress via regulation of the Nrf2 and PPARγ signaling pathway (Zhang et al. 2013; Bosch-Panadero et al. 2018) .
In the present study, BPA exposure induced oxidative stress both by TAC and MDA. Oxidative stress is caused by an imbalance between reactive oxygen species (ROS) and antioxidant defense system's ability to scavenge the reactive intermediates or to repair the consequence damages. TAC is an assay widely used to determine the antioxidant status. MDA is also an indicator of oxidative stress that is produced from lipid peroxidation. One of our study limitations is measurement of only TAC. We did not measure all antioxidant components and therefore, our study can only provide limited information about the antioxidant status. For example, this method does not evaluate the role of enzymes such as superoxide dismutase and catalase. Treatment with a dose of 150 mg/kg soy extract slightly changed TAC and MDA levels in the animals in the soy 2 group in comparison with control group. However, this dose had significantly greater effect when the animals were simultaneously exposed to BPA and soy. Our results are consistent with the experimental studies reporting on a link between BPA exposure and oxidative stress. In a similar study, Popa et al. (2014) have shown that Genista tinctoria by its antioxidant properties owing to rich isoflavones, could reduce MDA and hydroxyl radical generation induced by BPA.
Overproduction of oxidative stress could lead to damage of pancreatic β-cells, which are responsible for insulin biosynthesis and secretion (Ahangarpour et al. 2016) . Therefore, it seems that oxidative stress may be associated with glucose metabolism dysfunction induced by BPA in the present study. Isoflavones in soybeans could protect cells from damage through its antioxidant potential. As our results showed, a dose of 150 mg/kg soy extract could improve β-cell function and subsequently recover insulin and glucose levels, probably by reducing oxidative stress in these cells.
Effects on sex hormone levels through their ability to bind to estrogen and androgen receptors is one of the main mechanisms of BPA proposed by earlier studies (Acconcia et al. 2015) . Moreover, it has been reported that testosterone deficiency is common in men with diabetes, regardless of the type of diabetes (Grossmann et al. 2008) . For these reasons, we aimed to evaluate testosterone levels in male mice due to the scope of this investigation. In the current study, soy extract treatment did not alter serum levels of testosterone, whereas BPA noticeably reduced this hormone in all exposed BPA groups. Our finding supports previous work by Chouhan et al. (2015) who have reported that sperm count and serum testosterone level were reduced in treated mice by 100 μg/kg BPA.
It is likely that BPA may down-regulate steroidogenic acute regulatory protein (StAR) expression, leading to a decrease in testosterone biosynthesis. StAR is a transport protein primarily present in steroid-producing cells that is involved in the production of steroid hormones. In addition, BPA can prob-ably suppress testosterone production via activation of oxidative stress (Chouhan et al. 2015) . Similarly, data from present study revealed that oxidative stress might be responsible for reduced testosterone due to BPA exposure.
In agreement with our finding, Piotrowska et al. (2011) did not find any change in testosterone levels of rats treated with soy isoflavones despite the high dose used and the fact that exposure was during the critical prenatal life to sexual maturity period. In general, some studies have implied that there is an antioxidant potential role of soy isoflavones for improving the inflammatory and oxidative effects of BPA on the gonad Bernardo et al. 2015) , and thus soy isoflavones can maintain proper function of the male reproductive system. In contrary, a few studies have also indicated isoflavones reduced fertility and sperm quality along with a possibly antiandrogenic effect (Meena et al. 2017 ) that cannot be ignored in this context. In summary, several lines of evidence from our study suggested the protective effect of soy extract (150 mg/kg) on glucose metabolism dysfunction induced by BPA in mice co-exposed to BPA and soy extract. Further study on the molecular mechanisms underlying interaction effect of BPA and soy on glucose homeostasis will help understanding of the concerns associated with exposure to mixtures of EDCs.
Conclusion
BPA exposure caused a metabolic disorder along with increased oxidative stress in male mice. This study has been unable to demonstrate a possibility for synergic actions between soy extract and BPA because soy extract treatment could attenuate some adverse effects induced by BPA. Taken together, findings from this study highlighting that in agreement with earlier studies, significant effects of BPA in rodents at very low doses draws attention to potential risk in humans. Additional studies should be performed to establish the influence of endocrine disruptors in people at risk of high exposure such as infants fed soy-based formula by plastic bottles, chemical industry workers, and cashiers.
